Premium
TNF‐α's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression
Author(s) -
Ghali Olfa,
Chauveau Christophe,
Hardouin Pierre,
Broux Odile,
Devedjian JeanChristophe
Publication year - 2010
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.52
Subject(s) - mesenchymal stem cell , runx2 , apoptosis , microbiology and biotechnology , biology , cancer research , osteoblast , genetics , in vitro
Abstract RUNX2 is a bone‐specific transcription factor that plays a critical role in prenatal bone formation and postnatal bone development. It regulates the expression of genes that are important in committing cells into the osteoblast lineage. There is increasing evidence that RUNX2 is involved in osteoblast proliferation. RUNX2 expression increases during osteoblast differentiation, and recent data even suggest that it acts as a proapoptotic factor. The cytokine tumor necrosis factor α (TNF‐α) is known to modulate osteoblast functions in a manner that depends on the differentiation stage. TNF‐α affects the rate at which mesenchymal precursor cells differentiate into osteoblasts and induces apoptosis in mature osteoblasts. Thus we sought to establish whether or not the effects of TNF‐α and fetal calf serum on proliferation and apoptosis in human mesenchymal stem cells (hMSCs) were dependent on RUNX2 level and activity. We transfected hMSCs with small interfering RNAs (siRNAs) directed against RUNX2 and found that they proliferated more quickly than control hMSCs transfected with a nonspecific siRNA. This increase in proliferation was accompanied by a rise in cyclin A1, B1, and E1 expression and a decrease in levels of the cyclin inhibitor p21. Moreover, we observed that RUNX2 silencing protected hMSCs from TNF‐α's antiproliferative and apoptotic effects. This protection was accompanied by the inhibition of caspase‐3 activity and Bax expression. Our results confirmed that RUNX2 is a critical link between cell fate, proliferation, and growth control. This study also suggested that, depending on the osteoblasts' differentiation stage, RUNX2 may control cell growth by regulating the expression of elements involved in hormone and cytokine sensitivity. © 2010 American Society for Bone and Mineral Research